Sort by
Keyphrases
Malignancy
100%
Induction Therapy
100%
Post-transplant Lymphoproliferative Disorder
100%
Pediatric Heart Transplant
100%
Confidence Interval
40%
Hazard Ratio
40%
Risk of Malignancy
40%
Infection Risk
20%
Adverse Events
20%
Pediatric Patients
20%
Low Risk
20%
Congenital Heart Disease
20%
Fungal Infection
20%
Risk Determinants
20%
Epstein-Barr Virus
20%
OKT3
20%
Induction Agents
20%
Cytomegalovirus Infection
20%
Heart Transplant
20%
Early Infection
20%
Malignancy Rate
20%
Medicine and Dentistry
Infection
100%
Cancer
100%
Pediatrics
100%
Posttransplant Lymphoproliferative Disease
100%
Heart Transplantation
100%
Hazard Ratio
40%
Adverse Event
20%
Pediatrics Patient
20%
Heart Graft
20%
Persistent Truncus Arteriosus
20%
Epstein Barr Virus
20%
Anesthesia Induction
20%
Cytomegalovirus Infection
20%
Mycosis
20%
Induction Conclusion
20%
Nursing and Health Professions
Infection
100%
Heart Transplantation
100%
Posttransplant Lymphoproliferative Disease
100%
Confidence Interval
40%
Hazard Ratio
40%
Heart Graft
20%
Adverse Event
20%
Pediatrics Patient
20%
Anesthesia Induction
20%
Congenital Heart Disease
20%
Cytomegalovirus Infection
20%
Mycosis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Posttransplant Lymphoproliferative Disease
100%
Adverse Event
20%
Epstein-Barr Virus
20%
Mycosis
20%
Congenital Heart Disease
20%
Cytomegalovirus Infection
20%
Immunology and Microbiology
Heart Transplantation
100%
Infection
100%
Cytomegalovirus Infection
16%
Epstein Barr Virus
16%